Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 15-dehydro-prostaglandin E2. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

8 träffar

Bibliografisk träff 2023-07-19

Metabolic changes and potential biomarkers in "<i>Candidatus</i> Liberibacter solanacearum"-infected potato psyllids: implications for psyllid-pathogen interactions.

Li Y, Tan Z, Wang X, Hou L.

Front Plant Sci · research-article; journal article · DOI 10.3389/fpls.2023.1204305

Bibliografisk träff 2021-09-01

Ensemble Analysis Identifies Nasal 15-Keto-PGE2 as a Predictor of Recovery in Experimental Rhinovirus Colds.

Lane Starr NM, Evans MD, Lee KE, Gern JE, Denlinger LC.

J Infect Dis · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1093/infdis/jiab015

Bibliografisk träff 2020-11-04

Correction: 15-keto-prostaglandin E2 activates host peroxisome proliferator-activated receptor gamma (PPAR-γ) to promote Cryptococcus neoformans growth during infection.

Evans RJ, Pline K, Loynes CA, Needs S, Aldrovandi M, Tiefenbach J, Bielska E, Rubino RE, Nicol CJ, May RC, Krause HM, O'Donnell VB, Renshaw SA, Johnston SA.

PLoS Pathog · published erratum; correction · DOI 10.1371/journal.ppat.1009058

Bibliografisk träff 2019-03-28

15-keto-prostaglandin E2 activates host peroxisome proliferator-activated receptor gamma (PPAR-γ) to promote Cryptococcus neoformans growth during infection.

Evans RJ, Pline K, Loynes CA, Needs S, Aldrovandi M, Aldrovandi M, Tiefenbach J, Bielska E, Rubino RE, Nicol CJ, May RC, Krause HM, O'Donnell VB, Renshaw SA, Johnston SA.

PLoS Pathog · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.ppat.1007597

Bibliografisk träff 2016-01-28

Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2.

Chang EY, Chang YC, Shun CT, Tien YW, Tsai SH, Hee SW, Chen IJ, Chuang LM.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0147390

Bibliografisk träff 2015-11-01

15-Hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.

Lu D, Han C, Wu T.

J Biol Chem · retraction of publication; retraction notice · DOI 10.1074/jbc.a113.453886

Tillbakadragen publikation 2013-05-16

15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.

Lu D, Han C, Wu T.

J Biol Chem · retracted publication; research-article; journal article; research support, n.i.h., extramural · DOI 10.1074/jbc.m113.453886

Bibliografisk träff 2013-04-01

15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.

Lu D, Han C, Wu T.

Oncogene · research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/onc.2013.69